From 1cf4c1d991cfdfbc35a2f22ca1c6f2362c911448 Mon Sep 17 00:00:00 2001
From: Liliana Sanfilippo <lsanfilippo@techfak.uni-bielefeld.de>
Date: Tue, 3 Dec 2024 16:52:26 +0100
Subject: [PATCH] diagnosis q
---
src/contents/description.tsx | 9 +++++++--
1 file changed, 7 insertions(+), 2 deletions(-)
diff --git a/src/contents/description.tsx b/src/contents/description.tsx
index 654df00..0e6c15d 100644
--- a/src/contents/description.tsx
+++ b/src/contents/description.tsx
@@ -164,8 +164,13 @@ export function Description() {
</Collapsible>
</Subesction>
<Subesction title="Diagnosis" id="Cystic Fibrosis5">
- <p>With Cystic Fibrosis being a hereditary disease, the diagnostic methods have evolved significantly <SupScrollLink label="56"/> <SupScrollLink label="57"/> . Early diagnosis is crucial, as it allows for timely interventions that can improve the quality of life and longevity for CF patients <SupScrollLink label="56"/><sup>,</sup><SupScrollLink label="58"/>. With advancements in screening and diagnostic tools, many individuals are diagnosed shortly after birth, enabling early management of the disease <SupScrollLink label="56"/> <SupScrollLink label="61"/> .</p>
- <p>Cystic Fibrosis can be diagnosed through a variety of methods, often starting in infancy or even before birth <SupScrollLink label="56"/> <SupScrollLink label="60"/> . The most common diagnostic test is the newborn screening, which involves a blood test that checks for elevated levels of a protein called immunoreactive trypsinogen (IRT) <SupScrollLink label="59"/> <SupScrollLink label="61"/> . Elevated IRT levels can indicate potential CF, prompting further testing <SupScrollLink label="61"/> . </p>
+ <p>With Cystic Fibrosis being a hereditary disease, the diagnostic methods have evolved significantly. Early diagnosis is crucial, as it
+ allows for timely interventions that can improve the quality of life and longevity for CF patients<SupScrollLink label="37"/>{/* ehem58 */}.
+ With advancements in screening and diagnostic tools, many individuals are diagnosed shortly after birth, enabling early management of
+ the disease.</p>
+ <p>Cystic Fibrosis can be diagnosed through a variety of methods, often starting in infancy or even before birth. The most common diagnostic test
+ is the newborn screening, which involves a blood test that checks for elevated levels of a protein called immunoreactive trypsinogen
+ (IRT). Elevated IRT levels can indicate potential CF, prompting further testing <SupScrollLink label="31"/>{/* ehem61 */}. </p>
<Collapsible id="newborn-screening-collapsible" title="Newborn screening">
<p>Newborn screening for Cystic Fibrosis (CF) has been a major advancement in early detection and management, leading to significantly improved patient outcomes. This practice, which started in the late 1960s, became more widespread in the 1970s. The screening typically involves a blood test within the first few days of life, measuring immunoreactive trypsinogen (IRT), a marker that is elevated in newborns with CF. Elevated IRT levels prompt further genetic testing to identify CFTR mutations <SupScrollLink label="62"/> . If mutations are found, a sweat chloride test is often conducted to confirm the diagnosis. </p>
<p>Many countries, including the United States, Canada, the United Kingdom, Australia, and several European nations, have implemented newborn screening programs for CF. However, a survey of CF screening in Europe revealed that the implementation of such programs varies widely, with some countries adopting more comprehensive protocols than others <SupScrollLink label="63"/> . Early diagnosis through screening offers significant benefits, such as improved growth, better lung function, and overall enhanced health outcomes <SupScrollLink label="64"/> . The discovery of the CFTR gene has further refined diagnostic techniques and underscored the crucial role of newborn screening in the early detection and management of CF. </p>
--
GitLab